Stigmasterol sensitizes endometrial cancer cells to chemotherapy by repressing Nrf2 signal pathway.

Cancer Cell Int · 2020 · PMC7541302 · PMID 33041661

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

An increasing trend of Nrf2 expression was observed accompanying with the lesion progress from normal endometrial tissue, to hyperplasia and carcinoma tissue (Fig. 1 c).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.